Clinical Trial

Low Dose Edoxaban in Elderly Patients With AF and a History of Stroke

Study acronym: LEAVE-Stroke
Not Yet Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This prospectively enrolled, pragmatic randomized trial aims to investigate whether very low dose edoxaban regimen (15 mg daily) achieves similar edoxaban concentrations as low dose edoxaban regimen (30 mg daily), while maintaining a comparable risk of clinical outcomes and reducing major bleeding in elderly patients with atrial fibrillation and a history of ischemic stroke or transient ischemic attack.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-23.
Trial Details
NCT Number NCT06900725
Lead Sponsor National Taiwan University Hospital
Collaborators: National Taiwan University Hospital, Yun-Lin Branch, National Taiwan University Hospital Hsin-Chu Branch
Conditions Elderly, Atrial Fibrillation (AF), Ischemic Stroke
Enrollment 300 participants
Start Date 2025-04-01
Primary Completion 2030-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-04-02